Injection Guide
The most common GLP-1 side effect that doesn't appear on the label is lipohypertrophy: fatty lumps that form under the skin from injecting the same spot too often. Once the tissue changes, absorption in that area becomes unpredictable. The medication appears to stop working. In many cases, it hasn't — it just isn't getting in.
Updated August 2026 · 8 min read
Subcutaneous tissue absorbs medication through the capillary network just beneath the skin. Repeated injections in the same spot cause localized inflammation and fibrosis — the body's repair process for what it perceives as repeated injury. Over time, this creates dense, fibrous, fatty deposits that replace the normal tissue structure.
That changed tissue does not absorb drugs the same way. Studies in insulin-dependent diabetics — who face the same issue from daily injections — show absorption variability of 25-50% in lipohypertrophic sites compared to healthy tissue. For a weekly GLP-1 injection, that variability compounds. Week three of a titration might absorb 40% less than week one if you kept returning to the same abdominal site.
The lumps are usually not painful. That is part of the problem. You may prefer injecting into the same spot because the tissue there is desensitized and the injection stings less. You are choosing short-term comfort at the cost of consistent absorption.
Rotating properly means distributing injections across anatomically distinct zones with adequate rest between each use. Four anatomical areas, each with left and right sides, gives you 8 rotation zones. At one injection per week, cycling through all 8 means each zone gets 7 weeks of rest between injections.
Left and right abdomen
Fastest absorption. Keep injections at least 2 inches from the navel.
Left and right outer thigh
Good option for self-injection. Avoid the inner thigh.
Left and right upper arm
Slightly harder to self-inject. Good if someone assists.
Left and right upper glute
Requires some flexibility to self-inject. Solid rotation option.
Within each zone, vary your injection point by at least 1 inch from the previous injection in that area.
Healthy subcutaneous tissue in different locations absorbs at different rates. The abdomen has the most dense capillary network and absorbs fastest. The outer thigh is slower. The upper arm falls between the two.
For most GLP-1 users, these differences are clinically insignificant when the tissue is healthy. Once lipohypertrophy develops, the site-to-site variability becomes much larger than the normal anatomical differences. Injecting into a healthy upper arm is preferable to a damaged abdomen.
If you have been noticing GLP-1 effectiveness fluctuating week to week, check your injection sites before assuming the medication is failing. Run your finger over the areas you have been using. Lumps, firmness, or visible tissue changes under the skin are signs of lipohypertrophy.
A weekly injection schedule means seven days pass between each shot. Most people cannot reliably remember which zone they used seven days ago. They return to the site that feels familiar — which is often the one they have used most, which is the one they should be resting.
The solution is a log. It does not have to be sophisticated. A note in your phone, a paper calendar, or a purpose-built app all work. What matters is that you record the zone after each injection so you have actual information the following week instead of trying to recall from memory.
Protocol's 3D injection tracker
Protocol's free iOS and Android app maps all 8 zones on a 3D body model with color-coded recency. Green is rested. Orange is recent. Red is today. After each injection, you tap the zone used. The map tells you where to inject next week without requiring you to remember.
Download free on iOS and Android →Stop injecting into the affected sites immediately and do not return to them until the tissue normalizes. This takes weeks to months depending on how developed the lipohypertrophy is. Some cases resolve completely. Others leave permanent fatty deposits.
When you move to new sites, expect absorption to increase. Medication that was partially absorbed in damaged tissue will now absorb more completely. This can feel like the dose suddenly got stronger. If you experience increased side effects after changing injection sites, this is likely why — you are getting more of the drug than you were before.
If your GLP-1 effectiveness has been inconsistent, the single most impactful change you can make is strict site rotation going forward. Before adjusting your dose or switching medications, rule out absorption issues.
Track rotation in Protocol
Free 3D injection map with tissue-rest color coding. No account required. iOS and Android.
Lipohypertrophy is a buildup of fatty, fibrous tissue under the skin caused by repeated injections in the same site. The tissue changes the structure of the subcutaneous layer in that area, which slows and unpredictably alters drug absorption. A GLP-1 injected into a lipohypertrophic site may absorb 40-60% of the dose rather than the expected amount, making it appear that the medication is losing effectiveness when the real issue is poor rotation.
Clinical guidelines recommend rotating across at least 3-4 distinct anatomical zones: abdomen, outer thighs, and upper arms. Within each zone, you should also vary the specific injection point each time. Protocol's 3D body map tracks 8 zones with separate left and right sides for abdomen, outer thigh, and upper arm, plus upper glutes, giving you a large enough rotation pool to let each site rest adequately between uses.
The general guidance is at least 1 inch (2.5cm) from the previous injection point within the same zone, and a week or more before returning to the same general area. For weekly GLP-1 injections, rotating through 4-6 distinct zones means each site gets 4-6 weeks of rest between uses — more than adequate to prevent tissue buildup.
Yes. The abdomen is generally the fastest-absorbing site for subcutaneous injections. The outer thigh is slightly slower. The upper arm falls in between. These differences are clinically small for most patients, but the effect of injecting into damaged or lipohypertrophic tissue is significant — absorption can become unpredictable and substantially reduced.
Protocol's free iOS and Android app has a 3D injection site tracker that maps 8 zones with color-coded recency indicators. Green means the zone has had adequate rest. Orange means it was used recently. Red means it was used today. After each injection, you mark the zone used and the map updates. No account required to use it.